The combinatorial complexity of cancer precision medicine.
about
Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls"Threshold-crossing": A Useful Way to Establish the Counterfactual in Clinical Trials?Informing materials: drugs as tools for exploring cancer mechanisms and pathways.PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors.Precision oncology based on omics data: The NCT Heidelberg experience.Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric andTeen Patients Allows Identifying Two Main Classes of Biological ProcessesInvolved and New Potential Therapeutic TargetsThe hallmarks of premalignant conditions: a molecular basis for cancer preventionPrecision medicine for acute myeloid leukemiaA 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.Key signaling pathways in the muscle-invasive bladder carcinoma: Clinical markers for disease modeling and optimized treatment.Utilizing next-generation sequencing in the management of multiple myeloma.Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples.DNA methylation aberrancies as a guide for surveillance and treatment of human cancers.Semiconductor-based sequencing of formalin-fixed, paraffin-embedded colorectal cancer samples.Toward a Tiered Model to Share Clinical Trial Data and Samples in Precision Oncology.[Mutational tumor profiles beyond organ and tissue specificity: implications for diagnostics and clinical study design].[Limitations, pitfalls and perspectives of diagnostic massive parallel sequencing efforts in oncology].Precision medicine and oncology: an overview of the opportunities presented by next-generation sequencing and big data and the challenges posed to conventional drug development and regulatory approval pathways.Physiological random processes in precision cancer therapy.
P2860
Q28066709-B73086DA-2088-47C6-99E3-ED503F69E193Q28595570-D1D43BA4-6867-444A-9005-02748F3DDEACQ30402161-6305F0B2-4D98-4DDB-BE06-54E7496AB342Q35833018-0699C822-7783-4E45-AD05-3285259A552EQ36396606-CAD97F91-F335-46C7-B29E-AEF7532F1677Q36658489-A7DEE63E-2EDD-4849-8251-8D2551841ED6Q36679858-BC65D250-4105-4EEF-B908-675F36155F03Q36934758-E7A093AE-9C9C-4362-A3B4-C1A6F6CE0A31Q38584379-44DB0EB6-5459-4335-A1DF-D8889F6DFD7BQ38627721-3814ED5C-A1AE-420A-9301-D325698368E2Q38681814-2BBEE3AF-D515-4736-8078-50DBDD61E825Q39126105-81741070-6A9F-4DF6-BCA1-1C93572211A5Q39208639-7C429FCC-46D1-4D98-A2CC-8E0BB0C793BEQ42563204-4895B991-5B96-4B79-B2C9-C3C5347EE204Q50052181-90FA1FEC-9B16-45C9-A06F-7ABC97F914CCQ52872337-28969A35-9161-40EA-AC42-EB0A6FC41D04Q53337881-80E2D168-46D8-4F9B-872B-DBDE711CCEECQ53939793-D75743C4-6226-4E7D-B11E-81D25BBC9906Q55515912-EAEE2C77-237A-43D6-8C50-38C4C7F40A1E
P2860
The combinatorial complexity of cancer precision medicine.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The combinatorial complexity of cancer precision medicine.
@ast
The combinatorial complexity of cancer precision medicine.
@en
The combinatorial complexity of cancer precision medicine.
@nl
type
label
The combinatorial complexity of cancer precision medicine.
@ast
The combinatorial complexity of cancer precision medicine.
@en
The combinatorial complexity of cancer precision medicine.
@nl
prefLabel
The combinatorial complexity of cancer precision medicine.
@ast
The combinatorial complexity of cancer precision medicine.
@en
The combinatorial complexity of cancer precision medicine.
@nl
P2860
P50
P356
P1433
P1476
The combinatorial complexity of cancer precision medicine.
@en
P2093
Albrecht Stenzinger
Ulrich Keilholz
P2860
P304
P356
10.18632/ONCOSCIENCE.66
P577
2014-07-23T00:00:00Z